FindTrial
Sign In

A bidirectional, multicenter cohort study of inflammatory bowel disease (IBD) patients with nonalcoholic fatty liver disease (NAFLD)

A bidirectional, multicenter cohort study of inflammatory bowel disease (IBD) patients with nonalcoholic fatty liver disease (NAFLD)

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500101916
Enrollment
Unknown
Registered
2025-05-06
Start date
2025-05-06
Completion date
Unknown
Last updated
2025-05-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Inflammatory bowel disease

Interventions

IBD patients with non-alcoholic fatty liver disease:None
IBD patients without non-alcoholic fatty liver disease:None

Sponsors

Shanghai East Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1 Subjects older than 18 years old; 2 Subjects consistent with the Chinese consensus on the diagnosis and treatment of IBD; 3 Subjects able to cooperate with follow-up, participate in this study and sign the informed consent.

Exclusion criteria

Exclusion criteria: 1 Subjects with incomplete clinical data; 2 Subjects unable to cooperate with follow-up, refused to sign the informed consent; 3 Subjects unable to cooperate with the completion of relevant examinations; 4 Subjects with pregnant women; 5 Subjects with with severe heart, lung, kidney and other organ diseases or cancer, and expected survival time less than 6 months.

Design outcomes

Primary

MeasureTime frame
Clinical remission;Endoscopic remission;—

Secondary

MeasureTime frame
Clinical response;Endoscopic response;Improvement in quality of life;Adverse events;—

Countries

China

Contacts

Public ContactLan Zhong

Shanghai East Hospital

lanzhong@tongji.edu.cn+86 131 6209 9450

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026